Nihon Kohden (NHNKY) 12.9600 $NHNKY
Global Brain Computer Interface Market 2015 - Forecasts to 2020 for the $1.46 Billion Market
M2 - Wed May 13, 8:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/krhb95/global_brain) has announced the addition of the "Global Brain Computer Interface Market (Type, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. The Global Brain Computer Interface (BCI) market is expected to reach $1.46 billion by 2020, registering a CAGR of 11.5% during 2014-2020 A global rise in the count of brain disorders along with the increasing government funding to improve healthcare systems, would supplement the growth of this market. The non-invasive BCI technology accounted for about 85% of the total BCI market revenue in 2013, and demonstrate a steady growth in future, thus, eliminating the need to perform surgeries and implant BCI devices. Geographically, North America holds a major share in the BCI technology market due to high penetration of such technologies in this region. APAC is also a major contributor primarily to the vast computer gaming industry. The European region constitutes the third largest market and is expected to grow at a relatively higher CAGR during the forecast period. The European Commission is taking active measures for the population with motor disabilities. Key findings of the study: - The Global market for BCI would exhibit a steady growth owing to its increased adoption across key sectors such as healthcare and the gaming industry, during the forecast period (2014 - 2020). - The Invasive BCI technology market would grow at the fastest CAGR of 15.3% during 2014-2020. - Swift growth is expected in the smart home control applications segment due to high living standards in the North American region, especially across U.S. and Canada. - The Asia-Pacific market would foresee tremendous growth for BCI technology systems. The growth is also attributed to the stiff competition amongst the prominent market players leading to swift technological advances in the BCI systems. Players such as Emotiv, Inc., Advanced Brain Monitoring Inc. and Nihon Kohden Corporation are adopting a consistent development process of innovative products to penetrate the market and further enhance the overall revenues. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL BRAIN COMPUTER INTERFACE MARKET, BY TYPE CHAPTER 5 GLOBAL BRAIN COMPUTER INTERFACE MARKET BY, APPLICATION CHAPTER 6 GLOBAL BRAIN COMPUTER INTERFACE MARKET , BY GEOGRAPHY CHAPTER 7 COMPANY PROFILES - Nihon Kohden Corporation, - Mind Solutions Inc. - Advanced Brain Monitoring, Inc. - Quantum Applied Science and Research, Inc. - Cadwell Laboratories Inc. - OpenBCI - Cortech Solutions, Inc. - Neurosky, Inc - Emotiv, Inc - Guger Technologies OEG For more information visit http://www.researchandmarkets.com/research/kr...obal_brain
European Sleep Apnea Devices Market, by Segment, and Sleep Apnea Therapeutic Devices - Forecast to 2019
M2 - Wed May 06, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bjqw72/european_sleep) has announced the addition of the "European Sleep Apnea Devices Market, by Segment (Sleep Apnea Diagnostic Devices (Home Sleep Testing, Respiratory Polygraphs, Actigraphy Systems) and Sleep Apnea Therapeutic Devices (Pap Devices, Oxygen Devices, Airway Clearance Systems)-Forecast to 2019" report to their offering. The European sleep apnea devices market is projected to grow at a CAGR of 16.0% from 2014 to 2019 Germany holds the largest share of the European sleep apnea devices market. This large share of the German segment is attributed to the various driving forces, such as the increasing prevalence of sleep disorders in this region, increasing awareness level among patients and caregivers, rising number of cases of cardiovascular disorders, and the availability of technologically advanced diagnostic and therapeutic devices. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market in the coming years. The high costs associated with the diagnosis and treatment of sleep apnea also restrains the growth of devices market in this region. The research report classifies the European sleep apnea devices market on the basis of segment into sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on the types into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. The PAP devices segment is the largest contributor in the therapeutic devices market. Moreover, the therapeutic devices segment is the largest contributor to the overall European sleep apnea devices market, having accounted for a share of 58.1% in 2014. Further, the European sleep apnea devices market is segmented based on the major countries of the region, such as Germany, France, the U.K., Italy, Spain, and the Rest of Europe (RoE). Germany is the largest market for sleep apnea devices in Europe. It accounted for a share of 27.9% of the European sleep apnea devices market in 2014. The major factors contributing to its dominance are the increasing prevalence of sleep disorders, rising awareness among patients and caregivers, and availability of advanced diagnosis and therapy options. France is the second-largest market in Europe and is projected to grow at a CAGR of 16.6% from 2014 to 2019. The U.K. houses the fastest-growing segment of the European sleep apnea devices market, and is projected to grow at the fastest CAGR from 2014 to 2019. The rising research & development activities pertaining to sleep disorders, rising obesity rates, and increasing awareness levels among patients and caregivers, are some of the factors expected to drive the growth of the European sleep apnea devices market in the coming years. Companies Mentioned - Ambulatory Monitoring, Inc. - BMC Medical Co., Ltd. - Carefusion Corporation - Compumedics Limited - Devilbiss Healthcare - Fisher and Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Philips Respironics (Subsidiary of Philips Healthcare Ltd.) - Resmed, Inc. - Somnomedics Gmbh - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/bj...pean_sleep
BABY: 36.13 (-0.82)
North American Automated External Defibrillator (AED) Market 2015 - Forecast to 2019 for Semi-Automated External Defibrillators and Fully-Automated External Defibrillators
M2 - Wed Apr 29, 10:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3mpnvr/north_american) has announced the addition of the "North American Automated External Defibrillator (AED) Market by Product, by End-User - Forecast to 2019" report to their offering. The North American automated external defibrillator (AED) market is estimated to grow at a CAGR of 6.8% from 2014 to 2019. The U.S. held a larger share of the automated external defibrillator (AED) market with about 89.9% in 2013, followed by Canada. The North American automated external defibrillator (AED) market holds high potential for growth in future, due to a number of forces that favor this market. These include the rising incidences of cardiovascular diseases and sudden cardiac arrest (SCA), increasing awareness of SCA and the life-saving potential of AEDs, and an implementation of public access defibrillation programs in various countries. In this report, the North American automated external defibrillator (AED) market is broadly classified on the basis of product types, pricing of the equipment, and end-users. The products segment is classified into semi-automated external defibrillators and fully-automated external defibrillators. Based on end-users, the automated external defibrillator (AED) market is categorized into public facilities, hospitals, pre-hospitals, homecare & nursing homes, and others. Geographically, the market is divided into two countries, namely the U.S. and Canada. The U.S. is estimated to command the largest share of 89.9% of the North American automated external defibrillator (AED) market in 2013, followed by Canada. Canada is estimated to grow at a CAGR of 6.8% from 2014 to 2019. The U.S. forms the largest market for AEDs with about 200,000 units sold annually for public use. Strong competition in the U.S. market has brought about a significant decrease in AED costs. Following the enforcement of federal law that necessitates the installation of public access defibrillators (PAD), a large number of AEDs have been installed at public places in the U.S., resulting in growth in this region. The report has profiled the leading players of this market along with their developments (new product launches & partnerships, agreements, collaborations, and joint ventures) over the past few years and strategies adopted by them to sustain and strengthen their position in the North American automated external defibrillator (AED) market. Philips Healthcare (the Netherlands), Cardiac Science Corporation (U.S.), ZOLL Medical Corporation (U.S.), Physio-Control, Inc. (U.S.), NIHON KOHDEN CORPORATION (Japan), Defibtech, LLC (U.S.), and HeartSine Technologies, Inc. (U.S.) are some of the key players engaged in this market. For more information visit http://www.researchandmarkets.com/research/3m...h_american
Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019
M2 - Thu Apr 23, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lnxd5m/sleep_apnea) has announced the addition of the "Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019" report to their offering. The global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia. The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of sleep apnea in this region, increasing awareness level among patients and caregivers, and the availability of technologically advanced diagnostic and therapeutic devices. It is estimated that approximately 4% of men and 2% of women suffer from Obstructive Sleep Apnea (OSA) globally. Also, the rising prevalence of comorbidities (such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, among others) ensures that the global sleep apnea patient pool will grow in the coming years. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market during the forecast period, 2014 to 2019. In this report, the global sleep apnea devices market is broadly classified on the basis of segments, namely sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types, into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two-channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on types, into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. PAP devices segment is the highest contributor in the therapeutic devices market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Sleep Apnea Devices Market, By Type 6 Global Sleep Apnea Market, By Geography 7 Global Sleep Apnea Devices Market: Competitive Landscape 8 Sleep Apnea Devices Market, By Company - Advanced Brain Monitoring,Inc., - Ambulatory Monitoring, Inc. - Bmc Medical Co., Ltd. - Cadwell Laboratories, Inc. - Carefusion Corporation - Clevemed - Compumedics Limited - Fisher And Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Novasom - Philips Respironics (Subsidiary Of Philips Healthcare Ltd.) - Resmed, Inc. - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/ln...leep_apnea
BABY: 36.13 (-0.82)
Global Defibrillators Market 2015-2019 - Implantable Cardioverter Defibrillator (Single & Dual Chamber, CRT-D, & S-ICD) and External (Monitor/Defibrillator, AED, & Wearable)
M2 - Mon Apr 20, 4:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4vpdf/defibrillators) has announced the addition of the "Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Single & Dual Chamber, CRT-D, & S-ICD) and External (Monitor/Defibrillator, AED, & Wearable)), by End User (Hospital, Pre-hospital, Public Access, & Home) - Global Forecast to 2019" report to their offering. The global defibrillator market is estimated to grow $12.9 billion by 2019, at a CAGR of 6.9% from 2014 to 2019. Factors such as development of technologically advanced defibrillator, rapid growth in aging population with high risk of target diseases, rising incidences of cardiovascular disease, growing focus of public and private organizations and key market players toward public access defibrillator, and increasing number of training and awareness programs across the globe are propelling the growth of the market. However, lack of awareness about sudden cardiac arrest, issues related to the use of defibrillator devices (external and implantable), and unfavorable healthcare reforms in the U.S. are restraining the growth of this market. In addition to this, the increasing pricing pressure on market players and frequent product recalls are the key challenges faced by market players in the market. On the basis of regions, this market is classified into North America, Europe, Asia-Pacific, and Rest of the World. In 2014, North America is expected to dominate the global defibrillators market. Growth of this region can be attributed to the technological advancements and product innovations, increasing number of public defibrillation programs, rising prevalence of obesity, and rising focus of key players to expand their business in the North American region. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2014 to 2019, due to factors such as rapidly increasing aging population, growing focus of multinational companies on emerging markets, improving and modernizing healthcare infrastructure, and huge burden of cardiovascular disease in this region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global Defibrillators Market, By Product 8 Global Defibrillators Market, By End User 9 Defibrillator Market, By Region 10 Competitive Landscape 11 Company Profiles - Biotronik Se & Co.KG - Boston Scientific Corporation - Cardiac Science Corporation (A Subsidiary of Opto Circuits India Limited) - Heartsine Technologies, Inc. - Medtronic, Inc. - Nihon Kohden Corporation - Philips Healthcare (A Division of Koninklijke Philips N.V.) - Physio-Control, Inc. - ST. Jude Medical, Inc. - Sorin Group - Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation) For more information visit http://www.researchandmarkets.com/research/w4...brillators
BSX: 17.85 (-0.06), MDT: 76.42 (+0.16), STJ: 74.96 (+0.47)
Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019
M2 - Wed Apr 15, 4:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8w259s/global_sleep) has announced the addition of the "Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019" report to their offering. The Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 8.16 percent over the period 2014-2019. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches, waking up frequently to urinate, and dry mouth and sore in the morning. Sleep apnea diagnostic devices such PSG, actigraphy systems, and pulse oximeters are used for the screening of sleep apnea, while positive airway pressure and oral appliances are used for sleep apnea therapy. High adoption of home diagnostics for diagnosis of sleep apnea is a key trend ibn this market. Home diagnostics are convenient and cost-effective when compared to in-lab sleep tests and therefore are expected to propel the market growth. According to the report, high prevalence of sleep apnea disorder in people worldwide is a major driver in the market. The disorder is common in both adults and children and can result in hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence and cardiovascular diseases. Further, the report states that lack of patient compliance is a key challenges in the market. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia and nasal stuffiness contribute to non-compliance when using CPAP or BiPAP devices. Key Vendors - Fisher & Paykel Healthcare - Philips Healthcare - ResMed Other Prominent Vendors - Apnex Medical - Briggs Healthcare - Bunnell - Cadwell Laboratories - Carefusion - Clement Clarke International - Cleveland Medical Devices - Compumedics - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Embla Systems - GE Healthcare - Hamilton Medical - ImThera Medical - Invacare Corporation - Itamar Medical - Natus Medical - Nihon Kohden - Salter Labs - Teleflex Medical - Ventus Medical - Weinmann Gerate fur Medizin - Zephyr Sleep Technologies Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Types of Sleep Apnea - Disease Linked with the Sleep Apnea - Symptoms Associated with Sleep Apnea - Market Landscape - Global Sleep Apnea Diagnostic and Therapeutic Devices Market - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/8w...obal_sleep
BABY: 36.13 (-0.82), DHRM: 2.89 (+0.18), IVC: 21.62 (+1.11)
Nihon Kohden Names Dr. Wilson Constantine CEO of North America
Business Wire - Tue Apr 14, 6:00AM CDT
Nihon Kohden, a U.S. market leader in patient monitoring, sleep assessment, neurology and cardiology instrumentation solutions, has appointed Dr. Wilson P. Constantine the new chief executive officer of Nihon Kohden America. Constantine, who joined the company's U.S. operations as chief operating officer in September 2014, was named CEO as part of a reorganization that will allow the company to remain ahead of the needs of the rapidly changing U.S. healthcare market. He succeeds Fumio Izumida, who led the company through solid double digit growth between 2010 and 2015.
France Sleep Apnea Diagnostic Systems Market Growth Trends 2007-2020
M2 - Wed Apr 08, 8:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bcwwpc/france_sleep) has announced the addition of the "France Sleep Apnea Diagnostic Systems Market Growth Trends, 2014" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the sleep apnea diagnostic systems in France through 2020. The product categories covered in this report include: - Fixed Polysomnography Systems - Portable Polysomnography Systems Scope - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments Key Topics Covered: 1 Table of Contents 1.1 List of Tables 1.2 List of Charts 2. Introduction 3. Scope of the Report 4. French Market for Sleep Apnea Diagnostic Systems, 2007-2020 4.1 Sleep Apnea Diagnostic Systems, Revenue ($ mn) by Sub-Category, 2007-2020 4.2 Sleep Apnea Diagnostic Systems, Volume (Units) by Sub-Category, 2007-2020 4.3 Sleep Apnea Diagnostic Systems, Average Price ($), 2007-2020 4.4 Sleep Apnea Diagnostic Systems, Company Shares (%), 2014 5. Recent Events and Developments 6. Appendix Companies Mentioned - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - GE Sensing - Astro-Med, Inc. - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Embla Systems - ResMed Inc. - Natus Medical Incorporated - Nihon Kohden Corporation - Philips Medical Systems For more information visit http://www.researchandmarkets.com/research/bc...ance_sleep
ABT: 48.71 (+0.04), CAH: 87.55 (-0.45), COV: 106.71 (-1.36), EW: 131.41 (+0.85), BSX: 17.85 (-0.06), CMD: 85.85 (unch), BABY: 36.13 (-0.82), ALOT: 14.04 (-0.04), RMD: 56.20 (-0.26)
Global Automated External Defibrillator Market 2015-2019 with Nihon Kohden, Philips Healthcare & ZOLL Medical Dominating
PR Newswire Europe - Thu Apr 02, 9:18AM CDT
DUBLIN, Mar. 31, 2015 /PRNewswire/ --Research and Markets
Global Automated External Defibrillator Market 2015-2019 - Rise in Incidences of Sudden Cardiac Arrest
M2 - Tue Mar 31, 11:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3z843g/global_automated) has announced the addition of the "Global Automated External Defibrillator Market 2015-2019" report to their offering. The Global Automated External Defibrillator market to grow at a CAGR of 7.89 percent over the period 2014-2019. An automated external defibrillator can detect and identify life threating arrhythmias. In sudden cardiac arrest, the heartbeat suddenly stops and can result in death. However, sudden cardiac arrest is different from a heart attack. In a sudden cardiac arrest, the heart's electrical system is affected and it stops beating. The use of multifunction defibrillators is one of the key trends upcoming in this market. These devices can be used to monitor various parameters such as SpO2, non-invasive blood pressure, and partial pressure or concentration of CO2 in respiratory gases. According to the report, a rise in cholesterol levels, excessive smoking, and hypertension can lead to an increased incidence of cardiac disorders, which is resulting in high demand for automated external defibrillators. Various initiatives have been set up by governments and organizations in many countries to increase the use of public access defibrillators and this is propelling the growth of the market. Further, the report states that safety concerns associated with the use of defibrillators are inhibiting the growth of the market. The FDA reported a total of 28,000 cases of adverse effects between January 2005 and May 2010 in the US alone. These included patient injuries and deaths caused by the malfunction of devices. As a result of these adverse events, numerous products have been recalled by vendors. The Global Automated External Defibrillator market can be segmented into the revenue generated from the following segments: - Hospitals - Public Access Defibrillation Key Vendors - Nihon Kohden - Philips Healthcare - ZOLL Medical Other Prominent Vendors - Advanced Instrumentations - Adam, Rouilly - A.M.I. ITALIA S.R.L. - Cardiac Science (subsidiary of Opto Circuits) - CardiAid - Cardioline - Corpuls - EMTEL - E&M Electromedicina - Fukuda Denshi - Hagenuk - Innomed - Instramed - Laerdal - M&B Electronic Instruments - Mediana - Medical ECONET - Mindray - Nanoom Tech - Osatu S.Coop. - Physio Control - Prestan - Primedic - Schiller - Tecno-Gaz - WNL Products - XFT For more information visit http://www.researchandmarkets.com/research/3z..._automated
Eurpoean Automatic External Defibrillators (AED) Market 2015-2019
M2 - Mon Mar 30, 2:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/btl2zs/eurpoean) has announced the addition of the "Eurpoean Automatic External Defibrillators (AED) Market by Product Type (Semi-Automated, Fully-Automated), End-User (Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home) - Forecast to 2019" report to their offering. The European automated external defibrillator (AED) market is estimated to grow at a CAGR of 10.9% from 2014 to 2019 France held a larger share of the automated external defibrillator (AED) market with about 25.3% in 2014, followed by Germany. The European automated external defibrillator (AED) market holds high potential for growth in future, due to a number of forces that favor this market. These include the rising incidences of cardiovascular diseases & sudden cardiac arrest (SCA), increasing awareness of SCA & the life-saving potential of AEDs, and an implementation of public access defibrillation programs in various countries. However, product recalls have cost companies millions of dollars, affecting their revenues and in turn, having an adverse effect on the AED market. In this report, the European automated external defibrillator (AED) market is broadly classified on the basis of product types and end-users. The products segment is classified into semi-automated external defibrillators and fully-automated external defibrillators. Based on end-users, the automated external defibrillator (AED) market is categorized into pre-hospitals, public access market, hospitals, alternate care market, and home. Geographically, the market is divided into six countries, namely France, Germany, the U.K., Italy, Spain, and RoE. France is estimated to command the largest share of 25.3% of the European automated external defibrillator (AED) market in 2014, followed by Germany. Germany is estimated to grow at a CAGR of 9.2% from 2014 to 2019. European countries such as Italy and France passed various legislations that require installation of public access defibrillators in 2001 and 2007, respectively, authorizing the use of AED by a layperson. As a result of these laws and nationwide defibrillation programs undertaken by various local and national governments, a large number of AEDs have been installed at public places such as shopping centers, airports, offices, government buildings, schools, health and sports clubs, transportation centers, daycare centers, and casinos. Thus, the increasing installation of public access AEDs boosts the growth of this market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Automated External Defibrillator Market, By Type 6 Automated External Defibrillator Market, By End-User 7 Automated External Defibrillator Market, By Region 8 Automated External Defibrillator Market: Competitive Landscape 9 European Automated External Defibrillator Market: By Company - Cardiac Science Corporation - Heartsine Technologies, Inc. - Nihon Kohden Corporation - Philips Healthcare - Physio-Control - Zoll Medical Corporation For more information visit http://www.researchandmarkets.com/research/btl2zs/eurpoean
Nihon Kohden Secures Physiological Monitoring Contract with Premier, Inc.
Business Wire - Tue Mar 24, 6:00AM CDT
Nihon Kohden, a market leader in patient monitoring innovation, has procured a prestigious group purchasing agreement for physiological monitoring with Premier, Inc., a leading healthcare improvement company representing 3,400 U.S. hospitals and 110,000 other providers. Effective March 1, 2015, the new agreement gives Nihon Kohden the ability to sell its market-leading physiological monitoring products to Premier members across the continuum of care.
PINC: 38.07 (+0.05)
Spirometer Market International Research Report Review
PR Newswire - Mon Mar 23, 9:15PM CDT
2015 Market Research Report on Global Spirometer Industry is a 200 pages report added to DeepResearchReports.com in March'15.
CFN: 59.91 (-0.06)
Leading Global 100 Medical Technology Companies 2015
M2 - Mon Mar 23, 10:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x4m845/global_medical) has announced the addition of the "Global Medical Technology 100 - An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. The global medical technology industry's market size stands at approximately 350 billion U.S. dollars. Despite ongoing commercial challenges in 2014, the global medtech industry's financial performance held steady at the relatively low levels of growth that have become common in recent years. Global medtech industry needs to better differentiate products or face commoditization. The medical technology sector is expected to grow at a compound annual growth rate of 5 percent per year between 2013 and 2020 and the worldwide medtech sales are forecast to reach $514 billion by 2020. The in vitro diagnostics sector is expected to be the world's largest medtech segment in 2018, with sales of $54.5 billion, beating cardiology and diagnostic imaging to the top spot. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends in global medical technology industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical technology companies globally - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among leading global medical technology companies - International presence of global medical technology companies - R&D activities by global medical technology companies Key Topics Covered: Introduction Analysis Section: 1: Rankings of Medical Technology Companies Globally 1.1: Leading 100 Medical Technology Companies Globally (based on recent sales, net income, total assets, total equity) 1.2: Most Growing 25 Medical Technology Companies Globally 1.3: Most Profitable 25 Medical Technology Companies Globally 2: Stock Market Performance over 5 Years: Leading 25 Medical Technology Companies Globally News Section: 3: Key News of Medical Technology Sector Globally for Year 2014 3.1 - Key Company News: By Country and Company 3.2 - Key Company News: By News Category 3.3 - Key Industry News: By News Category 4: Important Alliances among Leading Medical Technology Companies Globally 5: International Presence of Global Medical Technology Companies 6: Research and Development Activities by Global Medical Technology Companies 7: Mergers and Acquisitions among Global Medical Technology Companies Companies Mentioned (Partial List) - Accuray Inc (United States) - Align Technology, Inc. (United States) - Boston Scientific Corporation (United States) - Draegerwerk AG & Co KGaA (Germany) - Geratherm Medical AG (Germany) - GN Store Nord A/S (Denmark) - Medistim ASA (Norway) - Nihon Kohden Corporation (Japan) - Nikon Corporation (Japan) - Optos PLC (United Kingdom) - Ossur hf. (Iceland) - Prognosys Medical Systems Private Limited (India) - Quality Systems India Healthacare Pvt Ltd (India) - Revenio Group Oyj (Finland) - Techno Horizon Holdings Co Limited (Japan) For more information visit http://www.researchandmarkets.com/research/x4...al_medical
BSX: 17.85 (-0.06), ALGN: 59.28 (-0.03), MDSY: 2.27 (-0.01), ARAY: 6.16 (+0.08)
South Africa Cardiovascular Surgery Market Analysis 2015-2020
M2 - Thu Mar 19, 9:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/78kc7k/south_africa) has announced the addition of the "South Africa Cardiovascular Surgery Market Analysis - Size, Share, Growth, Trends and Forecast Through 2007 - 2020" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the cardiovascular surgery in South Africa through 2020. The product categories covered in this report include: - Beating Heart Surgery Systems (BHS) - Cardiac Ablation Devices - Cardiopulmonary Bypass Equipment - Perfusion Disposables Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments. Key Topics Covered: 1. Tables & Charts 2. Introduction 3. Scope of the Report 4. South Africa Market for Cardiovascular Surgery, 2007-2020 5. Recent Events and Developments 6. Appendix Companies Mentioned - AtriCure, Inc. - MAQUET GmbH & Co. KG - Medtronic, Inc. - Nihon Kohden Corporation - OSI Systems, Inc. - Sorin Group - Terumo Medical Corporation For more information visit http://www.researchandmarkets.com/research/78...uth_africa
MDT: 76.42 (+0.16), OSIS: 70.99 (+0.39), ATRC: 21.46 (-0.43)
South Africa Cardiovascular Monitoring Systems Market Analysis 2015-2020
M2 - Thu Mar 19, 9:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m6tdz9/south_africa) has announced the addition of the "South Africa Cardiovascular Monitoring Systems Market Analysis - Size, Share, Growth, Trends and Forecast Through 2007 - 2020" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the cardiovascular monitoring systems in South Africa through 2020. The product categories covered in this report include: - ECG Monitoring Equipment (Electrocardiogram) - ECG Stress Testing Systems - Holter Monitoring System - Event Monitoring Systems Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments. Key Topics Covered: 1. Tables & Charts 2. Introduction 3. Scope of the Report 4. South Africa Market for Cardiovascular Monitoring Systems, 2007-2020 5. Recent Events and Developments 6. Appendix Companies Mentioned - LifeWatch, Corp. - Cardiac Science Corporation - Fukuda Denshi - GE Healthcare - Nihon Kohden Corporation - OSI Systems, Inc. - Philips Medical Systems - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/m6...uth_africa
OSIS: 70.99 (+0.39)
South Africa Cardiovascular Devices Market Opportunity and Growth Trend Forecasts to 2020
M2 - Thu Mar 19, 6:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v2nnrg/south_africa) has announced the addition of the "South Africa Cardiovascular Devices Market Opportunity and Growth Trend Forecast Till 2020" report to their offering. The Market Intelligence report provides critical market data for South Africa cardiovascular devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as cardiac assist devices, cardiac catheters and guidewires, cardiac rhythm management, cardiovascular heart valve and repair, cardiovascular monitoring systems, cardiovascular surgery, interventional cardiovascular devices, and peripheral vascular devices. Key Topics Covered: 1 Tables & Charts 2 Introduction 3 Scope of the Report 4 South Africa Market for Cardiovascular Devices (2007-2020) 5 South Africa Market for Cardiac Assist Devices (2007-2020) 6 South Africa Market for Cardiac Catheters and Guidewires (2007-2020) 7 South Africa Market for Cardiac Rhythm Management (2007-2020) 8 South Africa Market for Cardiovascular Heart Valve and Repair (2007-2020) 9 South Africa Market for Cardiovascular Monitoring Systems (2007-2020) 10 South Africa Market for Cardiovascular Surgery (2007-2020) 11 South Africa Market for Interventional Cardiovascular Devices (2007-2020) 12 South Africa Market for Peripheral Vascular Devices (2007-2020) 13 Recent Events and Developments 14 Appendix Companies Mentioned - Abbott Laboratories - AtriCure, Inc. - Biosense Webster, Inc. - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - C.R. Bard, Inc. - Cardiac Science Corporation - Cordis Corporation - Datascope Corp. - Edwards Lifesciences Corporation - ev3 Inc. - Fukuda Denshi Co., Ltd. - GE Healthcare - MAQUET GmbH & Co. KG - Medtronic, Inc. - Nihon Kohden Corporation - OSI Systems, Inc. - Philips Medical Systems - Sorin Group - St. Jude Medical Inc. - Terumo Corporation - Thoratec Corporation - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/v2...uth_africa
ABT: 48.71 (+0.04), BCR: 173.68 (+1.56), MDT: 76.42 (+0.16), EW: 131.41 (+0.85), OSIS: 70.99 (+0.39), ATRC: 21.46 (-0.43), BSX: 17.85 (-0.06), STJ: 74.96 (+0.47), THOR: 44.75 (-0.05)
Australia Multiparameter Patient Monitors Market Growth Trends Report 2015
M2 - Wed Mar 18, 11:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nmmbz7/australia) has announced the addition of the "Australia Multiparameter Patient Monitors Market Growth Trends, 2014" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the multiparameter patient monitors in Australia through 2020. The product categories covered in this report include: - Critical Care Monitors - Perioperative Care Monitors Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments. Key Topics Covered: 1 Tables & Charts 2. Introduction 3. Scope of the Report 4. Australian Market for Multiparameter Patient Monitors, 2007-2020 5. Recent Events and Developments 6. Appendix Companies Mentioned - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Fukuda Denshi Co., Ltd. - GE Healthcare - Maquet - Mindray Medical International Limited - Nihon Kohden Corporation - OSI Systems, Inc. - Philips Medical Systems - Schiller AG - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/nmmbz7/australia
CMD: 85.85 (unch), OSIS: 70.99 (+0.39), MR: 27.56 (+0.07)
Australia Blood Pressure Monitors Market Growth Trends Report 2015
M2 - Wed Mar 18, 11:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jm6zbn/australia_blood) has announced the addition of the "Australia Blood Pressure Monitors Market Growth Trends, 2014" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the blood pressure monitors in Australia through 2020. The product categories covered in this report include: - Mercury BP Monitors - Aneroid BP Monitors - Automatic BP Monitors Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments. Key Topics Covered: 1 Tables & Charts 2. Introduction 3. Scope of the Report 4. Australian Market for Blood Pressure Monitors, 2007-2020 5. Recent Events and Developments 6. Appendix Companies Mentioned - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - GE Sensing - GN ReSound A/S - Hartmann Group - LifeScan, Inc. - Matsushita Electrical Inddustrial Co., Ltd. - Medtronic, Inc. - Microlife Corporation - Mindray Medical International Limited - Natus Medical Incorporated - Nihon Kohden Corporation - OMRON HEALTHCARE Co., Ltd For more information visit http://www.researchandmarkets.com/research/jm...alia_blood
ABT: 48.71 (+0.04), MDT: 76.42 (+0.16), CAH: 87.55 (-0.45), COV: 106.71 (-1.36), EW: 131.41 (+0.85), MR: 27.56 (+0.07), BSX: 17.85 (-0.06), CMD: 85.85 (unch), BABY: 36.13 (-0.82), ALOT: 14.04 (-0.04)
Global Brain Computer Interface Market 2015 - Forecasts to 2020 for the $1.46 Billion Market
M2 - Wed May 13, 8:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/krhb95/global_brain) has announced the addition of the "Global Brain Computer Interface Market (Type, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. The Global Brain Computer Interface (BCI) market is expected to reach $1.46 billion by 2020, registering a CAGR of 11.5% during 2014-2020 A global rise in the count of brain disorders along with the increasing government funding to improve healthcare systems, would supplement the growth of this market. The non-invasive BCI technology accounted for about 85% of the total BCI market revenue in 2013, and demonstrate a steady growth in future, thus, eliminating the need to perform surgeries and implant BCI devices. Geographically, North America holds a major share in the BCI technology market due to high penetration of such technologies in this region. APAC is also a major contributor primarily to the vast computer gaming industry. The European region constitutes the third largest market and is expected to grow at a relatively higher CAGR during the forecast period. The European Commission is taking active measures for the population with motor disabilities. Key findings of the study: - The Global market for BCI would exhibit a steady growth owing to its increased adoption across key sectors such as healthcare and the gaming industry, during the forecast period (2014 - 2020). - The Invasive BCI technology market would grow at the fastest CAGR of 15.3% during 2014-2020. - Swift growth is expected in the smart home control applications segment due to high living standards in the North American region, especially across U.S. and Canada. - The Asia-Pacific market would foresee tremendous growth for BCI technology systems. The growth is also attributed to the stiff competition amongst the prominent market players leading to swift technological advances in the BCI systems. Players such as Emotiv, Inc., Advanced Brain Monitoring Inc. and Nihon Kohden Corporation are adopting a consistent development process of innovative products to penetrate the market and further enhance the overall revenues. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL BRAIN COMPUTER INTERFACE MARKET, BY TYPE CHAPTER 5 GLOBAL BRAIN COMPUTER INTERFACE MARKET BY, APPLICATION CHAPTER 6 GLOBAL BRAIN COMPUTER INTERFACE MARKET , BY GEOGRAPHY CHAPTER 7 COMPANY PROFILES - Nihon Kohden Corporation, - Mind Solutions Inc. - Advanced Brain Monitoring, Inc. - Quantum Applied Science and Research, Inc. - Cadwell Laboratories Inc. - OpenBCI - Cortech Solutions, Inc. - Neurosky, Inc - Emotiv, Inc - Guger Technologies OEG For more information visit http://www.researchandmarkets.com/research/kr...obal_brain
European Sleep Apnea Devices Market, by Segment, and Sleep Apnea Therapeutic Devices - Forecast to 2019
M2 - Wed May 06, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bjqw72/european_sleep) has announced the addition of the "European Sleep Apnea Devices Market, by Segment (Sleep Apnea Diagnostic Devices (Home Sleep Testing, Respiratory Polygraphs, Actigraphy Systems) and Sleep Apnea Therapeutic Devices (Pap Devices, Oxygen Devices, Airway Clearance Systems)-Forecast to 2019" report to their offering. The European sleep apnea devices market is projected to grow at a CAGR of 16.0% from 2014 to 2019 Germany holds the largest share of the European sleep apnea devices market. This large share of the German segment is attributed to the various driving forces, such as the increasing prevalence of sleep disorders in this region, increasing awareness level among patients and caregivers, rising number of cases of cardiovascular disorders, and the availability of technologically advanced diagnostic and therapeutic devices. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market in the coming years. The high costs associated with the diagnosis and treatment of sleep apnea also restrains the growth of devices market in this region. The research report classifies the European sleep apnea devices market on the basis of segment into sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on the types into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. The PAP devices segment is the largest contributor in the therapeutic devices market. Moreover, the therapeutic devices segment is the largest contributor to the overall European sleep apnea devices market, having accounted for a share of 58.1% in 2014. Further, the European sleep apnea devices market is segmented based on the major countries of the region, such as Germany, France, the U.K., Italy, Spain, and the Rest of Europe (RoE). Germany is the largest market for sleep apnea devices in Europe. It accounted for a share of 27.9% of the European sleep apnea devices market in 2014. The major factors contributing to its dominance are the increasing prevalence of sleep disorders, rising awareness among patients and caregivers, and availability of advanced diagnosis and therapy options. France is the second-largest market in Europe and is projected to grow at a CAGR of 16.6% from 2014 to 2019. The U.K. houses the fastest-growing segment of the European sleep apnea devices market, and is projected to grow at the fastest CAGR from 2014 to 2019. The rising research & development activities pertaining to sleep disorders, rising obesity rates, and increasing awareness levels among patients and caregivers, are some of the factors expected to drive the growth of the European sleep apnea devices market in the coming years. Companies Mentioned - Ambulatory Monitoring, Inc. - BMC Medical Co., Ltd. - Carefusion Corporation - Compumedics Limited - Devilbiss Healthcare - Fisher and Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Philips Respironics (Subsidiary of Philips Healthcare Ltd.) - Resmed, Inc. - Somnomedics Gmbh - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/bj...pean_sleep
BABY: 36.13 (-0.82)
North American Automated External Defibrillator (AED) Market 2015 - Forecast to 2019 for Semi-Automated External Defibrillators and Fully-Automated External Defibrillators
M2 - Wed Apr 29, 10:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3mpnvr/north_american) has announced the addition of the "North American Automated External Defibrillator (AED) Market by Product, by End-User - Forecast to 2019" report to their offering. The North American automated external defibrillator (AED) market is estimated to grow at a CAGR of 6.8% from 2014 to 2019. The U.S. held a larger share of the automated external defibrillator (AED) market with about 89.9% in 2013, followed by Canada. The North American automated external defibrillator (AED) market holds high potential for growth in future, due to a number of forces that favor this market. These include the rising incidences of cardiovascular diseases and sudden cardiac arrest (SCA), increasing awareness of SCA and the life-saving potential of AEDs, and an implementation of public access defibrillation programs in various countries. In this report, the North American automated external defibrillator (AED) market is broadly classified on the basis of product types, pricing of the equipment, and end-users. The products segment is classified into semi-automated external defibrillators and fully-automated external defibrillators. Based on end-users, the automated external defibrillator (AED) market is categorized into public facilities, hospitals, pre-hospitals, homecare & nursing homes, and others. Geographically, the market is divided into two countries, namely the U.S. and Canada. The U.S. is estimated to command the largest share of 89.9% of the North American automated external defibrillator (AED) market in 2013, followed by Canada. Canada is estimated to grow at a CAGR of 6.8% from 2014 to 2019. The U.S. forms the largest market for AEDs with about 200,000 units sold annually for public use. Strong competition in the U.S. market has brought about a significant decrease in AED costs. Following the enforcement of federal law that necessitates the installation of public access defibrillators (PAD), a large number of AEDs have been installed at public places in the U.S., resulting in growth in this region. The report has profiled the leading players of this market along with their developments (new product launches & partnerships, agreements, collaborations, and joint ventures) over the past few years and strategies adopted by them to sustain and strengthen their position in the North American automated external defibrillator (AED) market. Philips Healthcare (the Netherlands), Cardiac Science Corporation (U.S.), ZOLL Medical Corporation (U.S.), Physio-Control, Inc. (U.S.), NIHON KOHDEN CORPORATION (Japan), Defibtech, LLC (U.S.), and HeartSine Technologies, Inc. (U.S.) are some of the key players engaged in this market. For more information visit http://www.researchandmarkets.com/research/3m...h_american
Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019
M2 - Thu Apr 23, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lnxd5m/sleep_apnea) has announced the addition of the "Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019" report to their offering. The global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia. The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of sleep apnea in this region, increasing awareness level among patients and caregivers, and the availability of technologically advanced diagnostic and therapeutic devices. It is estimated that approximately 4% of men and 2% of women suffer from Obstructive Sleep Apnea (OSA) globally. Also, the rising prevalence of comorbidities (such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, among others) ensures that the global sleep apnea patient pool will grow in the coming years. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market during the forecast period, 2014 to 2019. In this report, the global sleep apnea devices market is broadly classified on the basis of segments, namely sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types, into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two-channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on types, into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. PAP devices segment is the highest contributor in the therapeutic devices market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Sleep Apnea Devices Market, By Type 6 Global Sleep Apnea Market, By Geography 7 Global Sleep Apnea Devices Market: Competitive Landscape 8 Sleep Apnea Devices Market, By Company - Advanced Brain Monitoring,Inc., - Ambulatory Monitoring, Inc. - Bmc Medical Co., Ltd. - Cadwell Laboratories, Inc. - Carefusion Corporation - Clevemed - Compumedics Limited - Fisher And Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Novasom - Philips Respironics (Subsidiary Of Philips Healthcare Ltd.) - Resmed, Inc. - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/ln...leep_apnea
BABY: 36.13 (-0.82)
Global Defibrillators Market 2015-2019 - Implantable Cardioverter Defibrillator (Single & Dual Chamber, CRT-D, & S-ICD) and External (Monitor/Defibrillator, AED, & Wearable)
M2 - Mon Apr 20, 4:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4vpdf/defibrillators) has announced the addition of the "Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Single & Dual Chamber, CRT-D, & S-ICD) and External (Monitor/Defibrillator, AED, & Wearable)), by End User (Hospital, Pre-hospital, Public Access, & Home) - Global Forecast to 2019" report to their offering. The global defibrillator market is estimated to grow $12.9 billion by 2019, at a CAGR of 6.9% from 2014 to 2019. Factors such as development of technologically advanced defibrillator, rapid growth in aging population with high risk of target diseases, rising incidences of cardiovascular disease, growing focus of public and private organizations and key market players toward public access defibrillator, and increasing number of training and awareness programs across the globe are propelling the growth of the market. However, lack of awareness about sudden cardiac arrest, issues related to the use of defibrillator devices (external and implantable), and unfavorable healthcare reforms in the U.S. are restraining the growth of this market. In addition to this, the increasing pricing pressure on market players and frequent product recalls are the key challenges faced by market players in the market. On the basis of regions, this market is classified into North America, Europe, Asia-Pacific, and Rest of the World. In 2014, North America is expected to dominate the global defibrillators market. Growth of this region can be attributed to the technological advancements and product innovations, increasing number of public defibrillation programs, rising prevalence of obesity, and rising focus of key players to expand their business in the North American region. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2014 to 2019, due to factors such as rapidly increasing aging population, growing focus of multinational companies on emerging markets, improving and modernizing healthcare infrastructure, and huge burden of cardiovascular disease in this region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global Defibrillators Market, By Product 8 Global Defibrillators Market, By End User 9 Defibrillator Market, By Region 10 Competitive Landscape 11 Company Profiles - Biotronik Se & Co.KG - Boston Scientific Corporation - Cardiac Science Corporation (A Subsidiary of Opto Circuits India Limited) - Heartsine Technologies, Inc. - Medtronic, Inc. - Nihon Kohden Corporation - Philips Healthcare (A Division of Koninklijke Philips N.V.) - Physio-Control, Inc. - ST. Jude Medical, Inc. - Sorin Group - Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation) For more information visit http://www.researchandmarkets.com/research/w4...brillators
BSX: 17.85 (-0.06), MDT: 76.42 (+0.16), STJ: 74.96 (+0.47)
Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019
M2 - Wed Apr 15, 4:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8w259s/global_sleep) has announced the addition of the "Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019" report to their offering. The Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 8.16 percent over the period 2014-2019. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches, waking up frequently to urinate, and dry mouth and sore in the morning. Sleep apnea diagnostic devices such PSG, actigraphy systems, and pulse oximeters are used for the screening of sleep apnea, while positive airway pressure and oral appliances are used for sleep apnea therapy. High adoption of home diagnostics for diagnosis of sleep apnea is a key trend ibn this market. Home diagnostics are convenient and cost-effective when compared to in-lab sleep tests and therefore are expected to propel the market growth. According to the report, high prevalence of sleep apnea disorder in people worldwide is a major driver in the market. The disorder is common in both adults and children and can result in hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence and cardiovascular diseases. Further, the report states that lack of patient compliance is a key challenges in the market. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia and nasal stuffiness contribute to non-compliance when using CPAP or BiPAP devices. Key Vendors - Fisher & Paykel Healthcare - Philips Healthcare - ResMed Other Prominent Vendors - Apnex Medical - Briggs Healthcare - Bunnell - Cadwell Laboratories - Carefusion - Clement Clarke International - Cleveland Medical Devices - Compumedics - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Embla Systems - GE Healthcare - Hamilton Medical - ImThera Medical - Invacare Corporation - Itamar Medical - Natus Medical - Nihon Kohden - Salter Labs - Teleflex Medical - Ventus Medical - Weinmann Gerate fur Medizin - Zephyr Sleep Technologies Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Types of Sleep Apnea - Disease Linked with the Sleep Apnea - Symptoms Associated with Sleep Apnea - Market Landscape - Global Sleep Apnea Diagnostic and Therapeutic Devices Market - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/8w...obal_sleep
BABY: 36.13 (-0.82), DHRM: 2.89 (+0.18), IVC: 21.62 (+1.11)
Nihon Kohden Names Dr. Wilson Constantine CEO of North America
Business Wire - Tue Apr 14, 6:00AM CDT
Nihon Kohden, a U.S. market leader in patient monitoring, sleep assessment, neurology and cardiology instrumentation solutions, has appointed Dr. Wilson P. Constantine the new chief executive officer of Nihon Kohden America. Constantine, who joined the company's U.S. operations as chief operating officer in September 2014, was named CEO as part of a reorganization that will allow the company to remain ahead of the needs of the rapidly changing U.S. healthcare market. He succeeds Fumio Izumida, who led the company through solid double digit growth between 2010 and 2015.
France Sleep Apnea Diagnostic Systems Market Growth Trends 2007-2020
M2 - Wed Apr 08, 8:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bcwwpc/france_sleep) has announced the addition of the "France Sleep Apnea Diagnostic Systems Market Growth Trends, 2014" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the sleep apnea diagnostic systems in France through 2020. The product categories covered in this report include: - Fixed Polysomnography Systems - Portable Polysomnography Systems Scope - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments Key Topics Covered: 1 Table of Contents 1.1 List of Tables 1.2 List of Charts 2. Introduction 3. Scope of the Report 4. French Market for Sleep Apnea Diagnostic Systems, 2007-2020 4.1 Sleep Apnea Diagnostic Systems, Revenue ($ mn) by Sub-Category, 2007-2020 4.2 Sleep Apnea Diagnostic Systems, Volume (Units) by Sub-Category, 2007-2020 4.3 Sleep Apnea Diagnostic Systems, Average Price ($), 2007-2020 4.4 Sleep Apnea Diagnostic Systems, Company Shares (%), 2014 5. Recent Events and Developments 6. Appendix Companies Mentioned - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - GE Sensing - Astro-Med, Inc. - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Embla Systems - ResMed Inc. - Natus Medical Incorporated - Nihon Kohden Corporation - Philips Medical Systems For more information visit http://www.researchandmarkets.com/research/bc...ance_sleep
ABT: 48.71 (+0.04), CAH: 87.55 (-0.45), COV: 106.71 (-1.36), EW: 131.41 (+0.85), BSX: 17.85 (-0.06), CMD: 85.85 (unch), BABY: 36.13 (-0.82), ALOT: 14.04 (-0.04), RMD: 56.20 (-0.26)
Global Automated External Defibrillator Market 2015-2019 with Nihon Kohden, Philips Healthcare & ZOLL Medical Dominating
PR Newswire Europe - Thu Apr 02, 9:18AM CDT
DUBLIN, Mar. 31, 2015 /PRNewswire/ --Research and Markets
Global Automated External Defibrillator Market 2015-2019 - Rise in Incidences of Sudden Cardiac Arrest
M2 - Tue Mar 31, 11:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3z843g/global_automated) has announced the addition of the "Global Automated External Defibrillator Market 2015-2019" report to their offering. The Global Automated External Defibrillator market to grow at a CAGR of 7.89 percent over the period 2014-2019. An automated external defibrillator can detect and identify life threating arrhythmias. In sudden cardiac arrest, the heartbeat suddenly stops and can result in death. However, sudden cardiac arrest is different from a heart attack. In a sudden cardiac arrest, the heart's electrical system is affected and it stops beating. The use of multifunction defibrillators is one of the key trends upcoming in this market. These devices can be used to monitor various parameters such as SpO2, non-invasive blood pressure, and partial pressure or concentration of CO2 in respiratory gases. According to the report, a rise in cholesterol levels, excessive smoking, and hypertension can lead to an increased incidence of cardiac disorders, which is resulting in high demand for automated external defibrillators. Various initiatives have been set up by governments and organizations in many countries to increase the use of public access defibrillators and this is propelling the growth of the market. Further, the report states that safety concerns associated with the use of defibrillators are inhibiting the growth of the market. The FDA reported a total of 28,000 cases of adverse effects between January 2005 and May 2010 in the US alone. These included patient injuries and deaths caused by the malfunction of devices. As a result of these adverse events, numerous products have been recalled by vendors. The Global Automated External Defibrillator market can be segmented into the revenue generated from the following segments: - Hospitals - Public Access Defibrillation Key Vendors - Nihon Kohden - Philips Healthcare - ZOLL Medical Other Prominent Vendors - Advanced Instrumentations - Adam, Rouilly - A.M.I. ITALIA S.R.L. - Cardiac Science (subsidiary of Opto Circuits) - CardiAid - Cardioline - Corpuls - EMTEL - E&M Electromedicina - Fukuda Denshi - Hagenuk - Innomed - Instramed - Laerdal - M&B Electronic Instruments - Mediana - Medical ECONET - Mindray - Nanoom Tech - Osatu S.Coop. - Physio Control - Prestan - Primedic - Schiller - Tecno-Gaz - WNL Products - XFT For more information visit http://www.researchandmarkets.com/research/3z..._automated
Eurpoean Automatic External Defibrillators (AED) Market 2015-2019
M2 - Mon Mar 30, 2:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/btl2zs/eurpoean) has announced the addition of the "Eurpoean Automatic External Defibrillators (AED) Market by Product Type (Semi-Automated, Fully-Automated), End-User (Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home) - Forecast to 2019" report to their offering. The European automated external defibrillator (AED) market is estimated to grow at a CAGR of 10.9% from 2014 to 2019 France held a larger share of the automated external defibrillator (AED) market with about 25.3% in 2014, followed by Germany. The European automated external defibrillator (AED) market holds high potential for growth in future, due to a number of forces that favor this market. These include the rising incidences of cardiovascular diseases & sudden cardiac arrest (SCA), increasing awareness of SCA & the life-saving potential of AEDs, and an implementation of public access defibrillation programs in various countries. However, product recalls have cost companies millions of dollars, affecting their revenues and in turn, having an adverse effect on the AED market. In this report, the European automated external defibrillator (AED) market is broadly classified on the basis of product types and end-users. The products segment is classified into semi-automated external defibrillators and fully-automated external defibrillators. Based on end-users, the automated external defibrillator (AED) market is categorized into pre-hospitals, public access market, hospitals, alternate care market, and home. Geographically, the market is divided into six countries, namely France, Germany, the U.K., Italy, Spain, and RoE. France is estimated to command the largest share of 25.3% of the European automated external defibrillator (AED) market in 2014, followed by Germany. Germany is estimated to grow at a CAGR of 9.2% from 2014 to 2019. European countries such as Italy and France passed various legislations that require installation of public access defibrillators in 2001 and 2007, respectively, authorizing the use of AED by a layperson. As a result of these laws and nationwide defibrillation programs undertaken by various local and national governments, a large number of AEDs have been installed at public places such as shopping centers, airports, offices, government buildings, schools, health and sports clubs, transportation centers, daycare centers, and casinos. Thus, the increasing installation of public access AEDs boosts the growth of this market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Automated External Defibrillator Market, By Type 6 Automated External Defibrillator Market, By End-User 7 Automated External Defibrillator Market, By Region 8 Automated External Defibrillator Market: Competitive Landscape 9 European Automated External Defibrillator Market: By Company - Cardiac Science Corporation - Heartsine Technologies, Inc. - Nihon Kohden Corporation - Philips Healthcare - Physio-Control - Zoll Medical Corporation For more information visit http://www.researchandmarkets.com/research/btl2zs/eurpoean
Nihon Kohden Secures Physiological Monitoring Contract with Premier, Inc.
Business Wire - Tue Mar 24, 6:00AM CDT
Nihon Kohden, a market leader in patient monitoring innovation, has procured a prestigious group purchasing agreement for physiological monitoring with Premier, Inc., a leading healthcare improvement company representing 3,400 U.S. hospitals and 110,000 other providers. Effective March 1, 2015, the new agreement gives Nihon Kohden the ability to sell its market-leading physiological monitoring products to Premier members across the continuum of care.
PINC: 38.07 (+0.05)
Spirometer Market International Research Report Review
PR Newswire - Mon Mar 23, 9:15PM CDT
2015 Market Research Report on Global Spirometer Industry is a 200 pages report added to DeepResearchReports.com in March'15.
CFN: 59.91 (-0.06)
Leading Global 100 Medical Technology Companies 2015
M2 - Mon Mar 23, 10:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x4m845/global_medical) has announced the addition of the "Global Medical Technology 100 - An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. The global medical technology industry's market size stands at approximately 350 billion U.S. dollars. Despite ongoing commercial challenges in 2014, the global medtech industry's financial performance held steady at the relatively low levels of growth that have become common in recent years. Global medtech industry needs to better differentiate products or face commoditization. The medical technology sector is expected to grow at a compound annual growth rate of 5 percent per year between 2013 and 2020 and the worldwide medtech sales are forecast to reach $514 billion by 2020. The in vitro diagnostics sector is expected to be the world's largest medtech segment in 2018, with sales of $54.5 billion, beating cardiology and diagnostic imaging to the top spot. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends in global medical technology industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical technology companies globally - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among leading global medical technology companies - International presence of global medical technology companies - R&D activities by global medical technology companies Key Topics Covered: Introduction Analysis Section: 1: Rankings of Medical Technology Companies Globally 1.1: Leading 100 Medical Technology Companies Globally (based on recent sales, net income, total assets, total equity) 1.2: Most Growing 25 Medical Technology Companies Globally 1.3: Most Profitable 25 Medical Technology Companies Globally 2: Stock Market Performance over 5 Years: Leading 25 Medical Technology Companies Globally News Section: 3: Key News of Medical Technology Sector Globally for Year 2014 3.1 - Key Company News: By Country and Company 3.2 - Key Company News: By News Category 3.3 - Key Industry News: By News Category 4: Important Alliances among Leading Medical Technology Companies Globally 5: International Presence of Global Medical Technology Companies 6: Research and Development Activities by Global Medical Technology Companies 7: Mergers and Acquisitions among Global Medical Technology Companies Companies Mentioned (Partial List) - Accuray Inc (United States) - Align Technology, Inc. (United States) - Boston Scientific Corporation (United States) - Draegerwerk AG & Co KGaA (Germany) - Geratherm Medical AG (Germany) - GN Store Nord A/S (Denmark) - Medistim ASA (Norway) - Nihon Kohden Corporation (Japan) - Nikon Corporation (Japan) - Optos PLC (United Kingdom) - Ossur hf. (Iceland) - Prognosys Medical Systems Private Limited (India) - Quality Systems India Healthacare Pvt Ltd (India) - Revenio Group Oyj (Finland) - Techno Horizon Holdings Co Limited (Japan) For more information visit http://www.researchandmarkets.com/research/x4...al_medical
BSX: 17.85 (-0.06), ALGN: 59.28 (-0.03), MDSY: 2.27 (-0.01), ARAY: 6.16 (+0.08)
South Africa Cardiovascular Surgery Market Analysis 2015-2020
M2 - Thu Mar 19, 9:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/78kc7k/south_africa) has announced the addition of the "South Africa Cardiovascular Surgery Market Analysis - Size, Share, Growth, Trends and Forecast Through 2007 - 2020" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the cardiovascular surgery in South Africa through 2020. The product categories covered in this report include: - Beating Heart Surgery Systems (BHS) - Cardiac Ablation Devices - Cardiopulmonary Bypass Equipment - Perfusion Disposables Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments. Key Topics Covered: 1. Tables & Charts 2. Introduction 3. Scope of the Report 4. South Africa Market for Cardiovascular Surgery, 2007-2020 5. Recent Events and Developments 6. Appendix Companies Mentioned - AtriCure, Inc. - MAQUET GmbH & Co. KG - Medtronic, Inc. - Nihon Kohden Corporation - OSI Systems, Inc. - Sorin Group - Terumo Medical Corporation For more information visit http://www.researchandmarkets.com/research/78...uth_africa
MDT: 76.42 (+0.16), OSIS: 70.99 (+0.39), ATRC: 21.46 (-0.43)
South Africa Cardiovascular Monitoring Systems Market Analysis 2015-2020
M2 - Thu Mar 19, 9:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m6tdz9/south_africa) has announced the addition of the "South Africa Cardiovascular Monitoring Systems Market Analysis - Size, Share, Growth, Trends and Forecast Through 2007 - 2020" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the cardiovascular monitoring systems in South Africa through 2020. The product categories covered in this report include: - ECG Monitoring Equipment (Electrocardiogram) - ECG Stress Testing Systems - Holter Monitoring System - Event Monitoring Systems Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments. Key Topics Covered: 1. Tables & Charts 2. Introduction 3. Scope of the Report 4. South Africa Market for Cardiovascular Monitoring Systems, 2007-2020 5. Recent Events and Developments 6. Appendix Companies Mentioned - LifeWatch, Corp. - Cardiac Science Corporation - Fukuda Denshi - GE Healthcare - Nihon Kohden Corporation - OSI Systems, Inc. - Philips Medical Systems - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/m6...uth_africa
OSIS: 70.99 (+0.39)
South Africa Cardiovascular Devices Market Opportunity and Growth Trend Forecasts to 2020
M2 - Thu Mar 19, 6:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v2nnrg/south_africa) has announced the addition of the "South Africa Cardiovascular Devices Market Opportunity and Growth Trend Forecast Till 2020" report to their offering. The Market Intelligence report provides critical market data for South Africa cardiovascular devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as cardiac assist devices, cardiac catheters and guidewires, cardiac rhythm management, cardiovascular heart valve and repair, cardiovascular monitoring systems, cardiovascular surgery, interventional cardiovascular devices, and peripheral vascular devices. Key Topics Covered: 1 Tables & Charts 2 Introduction 3 Scope of the Report 4 South Africa Market for Cardiovascular Devices (2007-2020) 5 South Africa Market for Cardiac Assist Devices (2007-2020) 6 South Africa Market for Cardiac Catheters and Guidewires (2007-2020) 7 South Africa Market for Cardiac Rhythm Management (2007-2020) 8 South Africa Market for Cardiovascular Heart Valve and Repair (2007-2020) 9 South Africa Market for Cardiovascular Monitoring Systems (2007-2020) 10 South Africa Market for Cardiovascular Surgery (2007-2020) 11 South Africa Market for Interventional Cardiovascular Devices (2007-2020) 12 South Africa Market for Peripheral Vascular Devices (2007-2020) 13 Recent Events and Developments 14 Appendix Companies Mentioned - Abbott Laboratories - AtriCure, Inc. - Biosense Webster, Inc. - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - C.R. Bard, Inc. - Cardiac Science Corporation - Cordis Corporation - Datascope Corp. - Edwards Lifesciences Corporation - ev3 Inc. - Fukuda Denshi Co., Ltd. - GE Healthcare - MAQUET GmbH & Co. KG - Medtronic, Inc. - Nihon Kohden Corporation - OSI Systems, Inc. - Philips Medical Systems - Sorin Group - St. Jude Medical Inc. - Terumo Corporation - Thoratec Corporation - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/v2...uth_africa
ABT: 48.71 (+0.04), BCR: 173.68 (+1.56), MDT: 76.42 (+0.16), EW: 131.41 (+0.85), OSIS: 70.99 (+0.39), ATRC: 21.46 (-0.43), BSX: 17.85 (-0.06), STJ: 74.96 (+0.47), THOR: 44.75 (-0.05)
Australia Multiparameter Patient Monitors Market Growth Trends Report 2015
M2 - Wed Mar 18, 11:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nmmbz7/australia) has announced the addition of the "Australia Multiparameter Patient Monitors Market Growth Trends, 2014" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the multiparameter patient monitors in Australia through 2020. The product categories covered in this report include: - Critical Care Monitors - Perioperative Care Monitors Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments. Key Topics Covered: 1 Tables & Charts 2. Introduction 3. Scope of the Report 4. Australian Market for Multiparameter Patient Monitors, 2007-2020 5. Recent Events and Developments 6. Appendix Companies Mentioned - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Fukuda Denshi Co., Ltd. - GE Healthcare - Maquet - Mindray Medical International Limited - Nihon Kohden Corporation - OSI Systems, Inc. - Philips Medical Systems - Schiller AG - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/nmmbz7/australia
CMD: 85.85 (unch), OSIS: 70.99 (+0.39), MR: 27.56 (+0.07)
Australia Blood Pressure Monitors Market Growth Trends Report 2015
M2 - Wed Mar 18, 11:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jm6zbn/australia_blood) has announced the addition of the "Australia Blood Pressure Monitors Market Growth Trends, 2014" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the blood pressure monitors in Australia through 2020. The product categories covered in this report include: - Mercury BP Monitors - Aneroid BP Monitors - Automatic BP Monitors Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments. Key Topics Covered: 1 Tables & Charts 2. Introduction 3. Scope of the Report 4. Australian Market for Blood Pressure Monitors, 2007-2020 5. Recent Events and Developments 6. Appendix Companies Mentioned - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - GE Sensing - GN ReSound A/S - Hartmann Group - LifeScan, Inc. - Matsushita Electrical Inddustrial Co., Ltd. - Medtronic, Inc. - Microlife Corporation - Mindray Medical International Limited - Natus Medical Incorporated - Nihon Kohden Corporation - OMRON HEALTHCARE Co., Ltd For more information visit http://www.researchandmarkets.com/research/jm...alia_blood
ABT: 48.71 (+0.04), MDT: 76.42 (+0.16), CAH: 87.55 (-0.45), COV: 106.71 (-1.36), EW: 131.41 (+0.85), MR: 27.56 (+0.07), BSX: 17.85 (-0.06), CMD: 85.85 (unch), BABY: 36.13 (-0.82), ALOT: 14.04 (-0.04)
